Evidence map›Paper›PMID 8436910›Full record

ArticleThe Journal of experimental medicine1993

Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.

A M Giusti, T Manser

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 62 citations in OpenAlex.

  1. The IgHFrontiers in immunology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  6. Article
  7. The reverse transcriptase model of somatic hypermutation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2001
    Review
  8. Article
  9. Article
  10. Article
  11. Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes.Proceedings of the National Academy of Sciences of the United States of America · 1993
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A M GiustiDepartment of Microbiology and Immunology, Jefferson Cancer Institute, Thomas Jefferson Medical College, Philadelphia, Pennsylvania 19107.
T Manser
Thomas Jefferson University · US

Funding

EXPRESSION OF ANTIBODY DIVERSITY DURING IMMUNE RESPONSESR01AI023739 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI MANSER, TIMOTHY L · 1986 to 2001
$481k
NIAID NIH HHS AI-23739
6 · The paper itself

Abstract

Mice with transgenes containing an antibody H chain V region (VHDJH) gene were used in an analysis of the cis-acting elements required for hypermutation of immunoglobulin (Ig) V genes. These transgenes can somatically recombine with endogenous IgH DNA, leading to the formation of functional heavy (H) chains partially encoded by the transgenic VHDJH. The transgenomes in the five different lines of mice analyzed contain as little as 150 bp, and as much as 2.8 kb of natural DNA flanking the 5' side of the VH and either 1.5 or 2.3 kb (including the intronic enhancer and 5' matrix attachment region [MAR]) flanking the 3' side of VH. Hybridomas were constructed from immunized transgenic mice, and transgenes present in these hybridomas that had or had not recombined to form functional H chain loci were sequenced. The data obtained show that: (a) the recombined transgenes contain hypermutated VH genes; and (b) among such transgenes, even those containing only 150 bp of natural VH 5' flanking sequence and several kilobases of 5' plasmid vector sequence display a frequency, distribution, and type of mutation characteristic of conventional IgH loci. The data also indicate that transgenic VHDJH genes that have not recombined with endogenous IgH DNA are not substrates for hypermutation, even if they are flanked by 2.8 kb of natural 5' DNA, and 2.3 kb of natural 3' DNA, including the JH2-JH4 region, a MAR, and the intronic enhancer. Collectively, the data suggest that sequences 5' of the VH promoter are dispensable, a VH promoter and the intronic IgH enhancer region are not sufficient, and a region(s) within or 3' of the IgH constant region locus is requisite, for hypermutation of Ig VH transgenes.

Indexed as

AnimalsBase SequenceChromosome MappingDNAEnhancer Elements, GeneticFemaleGene Expression Regulation, NeoplasticGenetic VectorsHybridomasImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionMaleMiceMice, TransgenicMolecular Sequence DataMutationDNAImmunoglobulin Heavy ChainsImmunoglobulin Variable Region

Identifiers

PMID8436910
PMCPMC2190935
OpenAlexW2166244403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.